COVID-19 Clinical Trials: 6 Operational Considerations You Should Evaluate
The following blog is a high-level overview of special considerations specific to clinical trials addressing COVID-19.
Read More
A 505(b)(2) Primer: Building the Bridge Between an Approved Drug and Your Novel Therapy
This blog features considerations and recommendations for sponsors exploring a 505(b)(2) pathway to drug approval. It was co-written by the Editors at Uncommon Conversations and the experts at Camargo.
Read More
Developing new scientists to meet increasing industry demand
The following blog highlights recent news surrounding Worldwide’s additions to its fellowship program and discusses the importance of preparing scientists and researchers to support tomorrow’s clinical trial needs.
Read More
A New Industry Standard: Raising the Bar on Data Monitoring
In the following blog, Worldwide provides insights on how it is setting a new industry standard on data management using the Comprehend Clinical Intelligence platform to optimize and monitor in a variety of trial use cases.
Read More
New Webinar Takes on Biosimilars Drug Development Challenges and Potential
The following blog serves as an introduction and overview of Worldwide’s recent webinar entitled, “Biosimilars: Death or Financial Burden,” presented by Hazel Gorham, Senior Director, Project Management for Worldwide Clinical Trials.
Read More
The Digital Age: Utilizing Social and Digital Media to Drive Patient Recruitment
In this blog post, Worldwide Clinical Trials previews its webinar featuring Barbara Zupancic, Senior Director, Patient Recruitment and Retention. The discussion focuses on the best ways to reach, inform, and recruit prospective patients.
Read More
